Purchase Order 75N90018P00523
Award Date 6/12/18
Potential Completion Date 6/11/20
Potential Value $611K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Auburndale, MA 02466, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The NIH Clinical Center issued a purchase order to Cardinal Health 414, LLC valued at $46,557.58 on December 31, 2019. The order represents a firm fixed-price administrative de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026 closing of the period of availability of these funds, in accordance with 31 U.S.C. Section 1552(a). Work is performed in Dublin, Ohio. No set-aside applied to this procurement.</p>
- This federal contract award is for a $38,999.10 purchase order issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health, Inc. for the supply of Floxuridine Vials for patient care. The contract was awarded on a sole-source, firm fixed-price basis under FAR Part 13 Simplified Acquisition Procedures, as Cardinal Health is the sole U.S. distributor of this medication. The contract has an ultimate completion date of March 11, 2026. Cardinal Health is a large, for-profit...
- Cardinal Health, Inc. was awarded a firm fixed-price purchase order valued at thirty-five thousand one hundred seventy-five dollars by the National Institutes of Health Clinical Center of the Department of Health and Human Services. Under this contract, Cardinal Health will provide floxuridine to the agency through March 2024 from its Dublin, Ohio facility. As the prime contractor, Cardinal Health will utilize its internal resources and supply chain to deliver the requested pharmaceutical to...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a $100,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Health and Human Services' National Institutes of Health Clinical Center. The delivery order is for the provision of FDA-approved radioactive drugs to the agency through September 30, 2021. No set-aside designation was applied to this award. Cardinal Health 414 will supply the radioactive...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 108, LLC, a subsidiary of Cardinal Health, Inc. The $48,432.00 firm fixed-price purchase order is for the supply of FLOXURIDINE VIALS and has an ultimate completion date of September 21, 2026. The contract is not set aside for any specific business type. Cardinal Health, Inc. is a global healthcare services and products company that provides a range of medical products and...
- The NIH Clinical Center issued a delivery order to Cardinal Health 200, LLC on April 15, 2019, with a ceiling value of $122,211.99 under the GSA Schedule for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The order has an ultimate completion date of April 17, 2021. Place of performance is Waukegan, Illinois. This is a firm fixed-price delivery order with no set-aside applied. The source indicates the order was subject to de-obligation of unexpended and expiring fiscal year 2021 funding in...
- <p>The NIH Clinical Center awarded a purchase order to Cardinal Health 414, LLC valued at $26,892.24 on October 1, 2019, for radiopharmaceutical products, with a firm fixed-price structure and no set-aside designation. The order was issued without competition following a pre-solicitation posted September 4, 2019. Performance occurs at Cardinal Health 414's facility in Dublin, Ohio. The ultimate completion date is December 31, 2019.</p>
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Metro Medical Supply, Inc., a subsidiary of the large healthcare company Cardinal Health, Inc. The $22,450.73 firm fixed-price purchase order was for the delivery of medical supplies and did not include a set-aside designation. The contract award appears to be part of a broader relationship between the NIH and Cardinal Health, which has a history of providing pharmaceutical distribution...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $4,251.00, is a Firm Fixed Price Delivery Order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract provides radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to support nuclear medicine, oncology, and other diagnostic imaging services at...
- Cardinal Health 414, LLC received a delivery order from the NIH Clinical Center valued at $117,677.26 for the supply of Fluorine-18 Fluorodeoxyglucose (F-18 FDG) in shielded delivery and administration systems. The contract, awarded on December 4, 2019, with an ultimate completion date of September 30, 2020, was issued on a firm fixed-price basis with no set-aside designation. Performance is based in Dublin, Ohio, where Cardinal Health 414 operates as a specialized subsidiary of Cardinal Health,...